UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria

This publication has 26 references indexed in Scilit:

• High expression of ubiquitin-conjugating enzyme 2C (UBE2C) correlates with nasopharyngeal carcinoma progression
  BMC Cancer, 2013
• Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer
  Korean Journal of Urology, 2013
• DNA methylation biomarkers of prostate cancer: Confirmation of candidates and evidence urine is the most sensitive body fluid for non‐invasive detection
  The Prostate, 2009
• Comparison of the Efficacy of Urine Cytology, Nuclear Matrix Protein 22 (NMP22), and Fluorescence in Situ Hybridization (FISH) for the Diagnosis of Bladder Cancer
  Korean Journal of Urology, 2009
• Circulating Nucleic Acids in Plasma and Serum
  Annals of the New York Academy of Sciences, 2008
• Detailed Technical Analysis of Urine RNA-Based Tumor Diagnostics Reveals ETS2/Urokinase Plasminogen Activator to Be a Novel Marker for Bladder Cancer
  Clinical Chemistry, 2007
• The value of combined use of survivin, cytokeratin 20 and mucin 7 mRNA for bladder cancer detection in voided urine
  Journal of Cancer Research and Clinical Oncology, 2007
• Patients’ perceived burden of cystoscopic and urinary surveillance of bladder cancer: a randomized comparison
  BJU International, 2007
• Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin
  Oncogene, 2004
• Current bladder cancer tests: unnecessary or beneficial?
  Critical Reviews in Oncology/Hematology, 2003